32^nd World Diabetes & Heart Congress

Welcome Message

Welcome to the 32nd World Diabetes & Heart Congress is an international conference that will be held on October 20–21, 2026 in Amsterdam Netherlands.We are delighted to bring together global experts to share knowledge, explore innovations, and advance care in diabetes and cardiovascular health. Wishing you a productive and enriching experience in Amsterdam.

About Conference

The 32nd World Diabetes & Heart Congress is an international conference that will be held on October 20–21, 2026 in Amsterdam Netherlands. The congress aims to inspire new strategies and foster global partnerships to address the growing challenges of diabetes and heart-related diseases. It brings together healthcare professionals, researchers, and experts to discuss the latest advancements in diabetes and cardiovascular health.

The conference focuses on improving prevention, diagnosis, and treatment through research, innovation, and collaboration, while providing a valuable platform for knowledge sharing and networking. It will feature keynote presentations, scientific sessions, panel discussions, and workshops led by renowned experts from around the world.

A wide range of topics will be covered, including diabetes management, cardiovascular diseases, emerging therapies, digital health technologies, and integrated care approaches. Participants will have the opportunity to present their research, exchange ideas, and build professional connections in a collaborative environment.

Session and tracks

 Diabetes and Metabolic Disorders:

The Diabetes and Metabolic Disorders is focuses on the underlying mechanisms of diabetes, including insulin resistance, beta-cell dysfunction, and metabolic syndrome. It also emphasizes early diagnosis, glycemic control strategies, and long-term management to prevent disease progression and complications.

Cardiovascular Complications in Diabetes:

The Cardiovascular Complications in Diabetes is highlights the strong association between diabetes and heart diseases. It covers coronary artery disease, heart failure, hypertension, and vascular inflammation, with special attention to risk reduction strategies and integrated cardio-diabetic care models.

Clinical Research and Therapeutics:

The Advanced Clinical Research and Therapeutics is  dedicated to ongoing clinical trials, novel pharmacological agents, and personalized medicine approaches. It explores new drug classes, combination therapies, and treatment guidelines aimed at improving patient outcomes and quality of life.

Clinical Research and Therapeutics:

The Clinical Research and Therapeutics is focuses on technological advancements in healthcare, including artificial intelligence in disease prediction, machine learning models for risk assessment, wearable biosensors, continuous glucose monitoring systems, and telemedicine applications for remote patient management.

Diabetes Complications:

The Diabetes Complications and Organ Damage is addresses microvascular and macrovascular complications such as diabetic neuropathy, nephropathy, retinopathy, and their impact on cardiovascular health. It also discusses multi-organ interaction and disease progression in chronic metabolic disorders.

Diabetic Nursing:

Diabetic Nursing is a registered nurse who specializes to work with patients who suffer from various conditions of diabetes. Diabetes nurses helps in explaining the condition of the patient clearly and help in understanding the treatment. They closely monitor the condition and identify any other health problems that may occur under the supervision of endocrinologists.

Diabetes devices and Technology

Diabetes treatment has changed drastically over the years with the development of new medical technologies. From talking meters to continuous glucose monitors, many of the recent innovations help you achieve better control.

• Diabetes apps
• Insulin Delivery Devices
• Glucometers and CGMs

Emerging Research and Translational Science:

The Emerging Research and Translational Science is presents cutting-edge developments in genomics, proteomics, stem cell research, and regenerative medicine. It aims to bridge the gap between laboratory discoveries and clinical applications in diabetes and heart disease treatment.

Nutrition, Lifestyle, and Preventive Medicine:

The Nutrition, Lifestyle, and Preventive Medicine is emphasizes the role of diet, physical activity, behavioral modification, and public health interventions in preventing diabetes and cardiovascular diseases. It also highlights patient education, community health programs, and sustainable lifestyle strategies.

Diabetes mellitus:

It is a chronic metabolic disorder characterized by elevated blood glucose levels due to defects in insulin secretion, insulin action, or both. It is a major global health concern due to its high prevalence and potential complications affecting multiple organs, including the heart, kidneys, eyes, and nerves.

Pathophysiology of Diabetes:

Diabetes mellitus is a metabolic disorder characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The pathophysiology varies depending on the type of diabetes.

Diabetes Complications:

Diabetes mellitus is associated with both acute and chronic complications due to prolonged hyperglycemia, metabolic imbalances, and vascular damage. Complications affect multiple organ systems and significantly impact morbidity and mortality.

Cardiology:

Cardiology is the branch of medicine that deals with the structure, function, and disorders of the heart and blood vessels. It encompasses the diagnosis, treatment, and prevention of cardiovascular diseases (CVDs), which are among the leading causes of morbidity and mortality worldwide.

Heart devices and cardiovascular technology:

Heart devices and cardiovascular technology are crucial innovations in diagnosing, monitoring, and treating heart diseases. Advances in medical engineering and digital health have transformed cardiology, allowing for minimally invasive procedures, improved patient outcomes, and better disease management.

Pediatric Cardiology:

Pediatric Cardiology deals with complications related to heart in children.  They may be genetic or hereditary.

Heart Regeneration:

 Heart Regeneration is defined as the regeneration of heart tissue which aims in repairing irreversible damaged tissue with stem cell and cell-free therapy.  Reparative tools are used to promote body’s natural regenerating capabilities.  However adult human cells don’t have the capability to divide and regenerate hence the damaged tissue is being replaced with healthy tissue also called as scar tissue.

Cardiology Case Reports:

Cardiology Case Reports are detailed clinical accounts of unique, rare, or complex heart conditions. They provide valuable insights into diagnosis, management, and outcomes, allowing healthcare professionals to learn from real-world experiences.

Obesity & Stroke:

Obesity is a condition in which abundance muscle to fat ratio is collected to the degree that it might negatively affect health. Individuals when their body mass index (BMI), compared to that of an average man's weight by the square of the individual's stature, is more than 30 kg/m2, with the range 25– 30 kg/m2 characterized as overweight. Obesity is one of the major health concern worldwide.  Obesity causes severe health complications including diabetes, high chance of cardiac arrest, asthma, Bariatric surgery is compared with a typical medical care. Bariatric surgery is being currently used with some treatment algorithms for the medical management of patients with T2DM and several fatness.

 Diagnosis and Medications:

Accurate diagnosis and timely medication management are the cornerstones of effective treatment for both diabetes and cardiovascular diseases (CVDs). These strategies reduce complications, improve quality of life, and enhance patient survival.

Why to attend

Why to attend:

• Opportunity to meet world’s Diabetes, Obesity & Heart Experts
• Keynote forums by renowned Physicians & Professors
• Plenary talks and Poster presentations by global experts
• Best platform for Global business and networking opportunities
• Oral & Poster presentations by Young Researchers
• Best poster & Young Research Forum awards

Who to attend

Who to attend:

Faculty Members and Researchers:

•  Keynote Speech
•  Plenary Speech
•  Poster Presentation
•  Symposium (4-5 member team)        
•  Workshop

Universities, Associations & Societies:

•   Association Partnering
•   Academic Partnering  
•   Group Participation

Students and Research Scholars:

•   Poster Competition (Best Poster Award)       
•   Young Researcher Forum (YRF Award)
•   Group Participation  

Business Delegates:

•   Speaker Presentations
•   Symposium hosting   
•   Book Launch event   
•   Networking opportunities      
•   Audience participation

Product Manufacturers:

•   Exhibitor and Vendor booths
•   Sponsorship opportunities
•   Product launch
•   Workshop
•   Scientific Partnering
•   Marketing and Networking with clients

Market Analysis

Market analysis:

The global market for diabetes and cardiovascular medical devices  represents a rapidly expanding sector in healthcare. According to recent figures from the International Diabetes Federation (IDF), the worldwide market for diabetes care devices, including insulin delivery systems, glucose monitoring devices, and cardiovascular therapeutic gadgets, exceeded  $55 billion in 2025, with a projected annual growth rate of 6–7% over the next five years. The U.S., Europe, and Japan remain the largest regional markets, with emerging demand in Asia-Pacific and Middle East  markets due to increasing prevalence of diabetes and cardiovascular diseases.

The diabetes segment includes continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, test strips, and wearable monitoring devices, which are increasingly integrated with digital platforms for real-time data tracking and telemedicine applications. Meanwhile, the cardiology segment comprises pacemakers, implantable cardioverter-defibrillators (ICDs), stents, balloon catheters, cardiac imaging devices, and heart failure assist devices.

The global cardiovascular devices market in 2025 was valued at approximately $68 billion, driven by rising incidence of coronary artery disease, heart failure, and arrhythmias. Subsegments include coronary stents, angioplasty balloons, intravascular imaging catheters (IVUS, OCT), guide wires, introducer sheaths, and fractional flow reserve (FFR) guide wires.

The market is expected to continue its growth trajectory due to:

• Aging populations  in developed countries with high incidence of diabetes and heart disease.
• Increased prevalence of lifestyle-related diseases  such as obesity, hypertension, and type 2 diabetes in developing regions.
• Technological innovation, including AI-assisted diagnostic tools, minimally invasive devices, and wearable monitoring technologies.
• Regulatory support and reimbursement programs that facilitate adoption of advanced medical devices.

Conclusion: The integrated diabetes and cardiology devices market presents a significant opportunity for innovation, research, and industry engagement, making conferences like the 32nd World Diabetes & Heart Congress – Expert Meets 2026, scheduled for October 20–21, 2026, in Amsterdam, Netherlands, an essential platform for showcasing technology, facilitating partnerships, and advancing clinical knowledge globally.

Participants & Participation options

Participants & participation options    

• Speaker: Deliver keynote or invited lectures, share research and innovations with global delegates.
• Delegate: Attend sessions, panel discussions, networking events; access conference materials and expert interactions.
• Poster Presenter: Showcase original research via printed or digital posters; engage in one-on-one discussions.
• Exhibitor: Display products, technologies, or services; network with delegates and potential collaborators.
• Video Presentation: Present research via recorded sessions; ideal for those unable to attend in person.
• E-Poster Presenter: Share research electronically; participate in virtual Q&A and discussions.
• Virtual Registration: Attend live-streamed sessions, access recordings, materials, and virtual networking; ideal for international participants.

Participant Benefits

• Earn CPD/CME points
• Networking with global experts and peers
• Certificate of participation
• DOI publication opportunities in conference proceedings
• Access to cutting-edge research
• Professional visibility for speakers, presenters, and exhibitors
• Opportunities for global collaboration

Abstract Submission & Registration Timeline

• Abstract Submission: Now Open
• Early Bird Registration: May 28th, 2026
• Standard Registration: June 29th, 2026
• Final Registration Deadline: October 20th, 2026

Abstract Details: Peer-reviewed; accepted abstracts published in proceedings with DOI for global visibility. Authors receive an Abstract Acceptance Letter confirming inclusion.

Secure Your Place & Submit Your Abstract

• Registration Link: https://diabetes-heartexperts.diabetesexpo.com/registration.php
• Abstract Submission Link: https://diabetes-heartexperts.diabetesexpo.com/abstract-submission.php

Don’t miss the opportunity to participate, present your research, and network with global experts.

For Inquiries:

• Email: diabetesexperts@asiaconvention.com
• Phone: +44 2045861247
• Website: https://diabetes-heartexperts.diabetesexpo.com/